This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: lncRNA FEZF1-AS1 Is Associated with Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research · RNA modifications and cancer
The published article titled “lncRNA FEZF1-AS1 Is Associated with Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion” has been retracted from Oncology Research, Vol. 27, No. 1, 2019, pp. 39–45.
DOI: 10.3727/096504018X15199482824130
URL: https://www.techscience.com/or/v27n1/48658
The authors requested this retraction, informing the Editorial Office that some critical errors were presented in Fig. 2, Fig. 3 and Fig. 4, due to improper copying and reversal of the figure elements, duplication with figures published in other articles.
Following a review by the Editorial Board, the reasons provided for the retraction were found to be valid and detailed. All authors agreed to the retraction, and it was subsequently approved by the Editor-in-Chief.
As a responsible publisher, we hold the reliability and integrity of our published content in high regard. We deeply regret any inconvenience caused by this situation to our readers and all concerned parties.